Preventing birth risks
Evidence-based guidance on low-dose aspirin prophylaxis to reduce preeclampsia and preterm birth, supporting maternal and fetal health.
Protocol • 2024
Aspirin Prophylaxis
Evidence-based clinical guide
Evidence-based prophylaxis for maternal health
PREVENTA synthesizes landmark trial data to provide clinicians with clear, actionable protocols for preventing preeclampsia and preterm birth.
Understanding the vascular benefits of low-dose aspirin.
Evidence suggests that aspirin modulates the COX-1 pathway, improving placental perfusion and reducing the risk of preeclampsia in high-risk pregnancies.
COX-1 Inhibition
Selective inhibition of thromboxane A2 while preserving endothelial prostacyclin synthesis.
Spiral Artery Flow
Promotes physiological transformation of uterine arteries to improve placental perfusion.
Clinical Registry
Validated by ACOG and USPSTF guidelines for high-risk pregnancy management.
Mechanism of Action
Low-dose aspirin acts as a targeted prophylactic to optimize placental perfusion and mitigate the risk of preeclampsia.
Low-dose aspirin selectively inhibits cyclooxygenase-1, reducing thromboxane A2 production to prevent platelet aggregation and vascular constriction.
Promotes healthy trophoblast invasion and spiral artery remodeling, ensuring high-flow, low-resistance placental perfusion.
Reduces the risk of preterm preeclampsia by stabilizing the maternal-fetal interface through evidence-based prophylactic dosing.
Initiation and Administration
Evidence-based guidelines for prophylactic aspirin use to prevent preeclampsia and preterm birth.
Review Clinical Evidence
Access full trial data and committee opinions on prophylactic aspirin.
Standardize aspirin prophylaxis for maternal health.
Access validated clinical protocols, risk screening checklists, and patient counseling materials designed to prevent preeclampsia and improve maternal-fetal outcomes.
Protocol Components:
- Chronic hypertension risk assessment
- Prior preeclampsia history screening
- BMI & maternal age factor analysis
Protocol Components:
- Optimal initiation window (12-16w)
- COX-1 inhibition mechanism review
- Safety profile & contraindications
Protocol Components:
- Evidence-based benefit summaries
- Addressing maternal safety concerns
- Adherence tracking & support
Download the clinical protocol suite.
Access printable checklists, dosage calculators, and patient education brochures to support evidence-based care in your practice.